[PAR] QoQ Quarter Result on 30-Jun-2023 [#Q4]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q4]
Profit Trend
QoQ- 37.10%
YoY- -63.42%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/24 30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 CAGR
Revenue 17 66 0 42 5 34 45 -27.68%
PBT -6,255 -14,681 -50,020 -26,309 -32,643 -12,265 -26,985 -38.54%
Tax -331 -4,986 -1,061 -6,266 -776 0 0 -
NP -5,924 -9,695 -48,958 -20,043 -31,867 -12,265 -26,985 -39.64%
Tax Rate - - - - - - - -
Total Cost 5,941 9,761 48,958 20,085 31,872 12,299 27,030 -39.62%
Ratio Analysis
31/12/24 30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 CAGR
NP Margin -35,473.37 -14,734.04 0.00 -47,664.68 -676,581.74 -36,048.08 -59,701.33 -15.91%
Per Share
31/12/24 30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 CAGR
EPS -0.02 -0.03 -0.16 -0.07 -0.12 -0.05 -0.11 -43.31%
EPS Diluted -0.02 -0.03 -0.16 -0.07 -0.12 -0.05 -0.11 -43.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.